ACT Network

The Accrual to Clinical Trials (ACT) Network is a real-time platform allowing researchers to explore and validate feasibility for clinical studies across the NCATS Clinical and Translational Science Award (CTSA) consortium, from their desktops. ACT helps researchers design and complete clinical studies, and is secure, HIPAA-compliant and IRB-approved. Learn more

  • Event
    Banner image for the ACT Network COVID-19 webinar May 5, 2020
    Using the ACT network to gain insight into COVID-19